Breeden v. Novartis Pharmaceuticals Corp.

181 L. Ed. 2d 981, 132 S. Ct. 1116, 565 U.S. 1158, 2012 U.S. LEXIS 853, 80 U.S.L.W. 3425, 2012 WL 117582
Supreme Court of the United States·Decided January 17, 2012·No. No. 11-669·Published

Opinion

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.

Same case below, 396 U.S. App. D.C. 170, 646 F.3d 43.

Free access — add to your briefcase to read the full text and ask questions with AI

Breeden v. Novartis Pharmaceuticals Corp., 181 L. Ed. 2d 981, 132 S. Ct. 1116, 565 U.S. 1158, 2012 U.S. LEXIS 853, 80 U.S.L.W. 3425, 2012 WL 117582 (U.S. 2012).

181 L. Ed. 2d 981 (Breeden v. Novartis Pharmaceuticals Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Breeden v. Novartis Pharmaceuticals Corp.
646 F.3d 43 (D.C. Circuit, 2011)